Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real‐world evidence

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-11-24
DOI
https://doi.org/10.1111/jdv.70114
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real‐world evidence

Marjolein S. de Bruin-Weller, Lian F. van der Gang
Journal of the European Academy of Dermatology and Venereology
Dermatology and Skin Diseases
article

Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real‐world evidence

Marjolein S. de Bruin-Weller, Lian F. van der Gang
article en

Abstract

No abstract available for this paper.
Journal of the European Academy of Dermatology and VenereologyVol. 39(12)
University Medical Center Utrecht (NL)
Openalex Percentile: Top 40%
Dermatology and Skin Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real‐world evidence — Marjolein S. de Bruin-Weller, Lian F. van der Gang · Journal of the European Academy of Dermatology and Venereology (2025) | TGRS Research Map | TGRS